FR2160542B1 - - Google Patents

Info

Publication number
FR2160542B1
FR2160542B1 FR7240734A FR7240734A FR2160542B1 FR 2160542 B1 FR2160542 B1 FR 2160542B1 FR 7240734 A FR7240734 A FR 7240734A FR 7240734 A FR7240734 A FR 7240734A FR 2160542 B1 FR2160542 B1 FR 2160542B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7240734A
Other languages
French (fr)
Other versions
FR2160542A1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Original Assignee
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV filed Critical Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Publication of FR2160542A1 publication Critical patent/FR2160542A1/fr
Application granted granted Critical
Publication of FR2160542B1 publication Critical patent/FR2160542B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7240734A 1971-11-17 1972-11-16 Expired FR2160542B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (2)

Publication Number Publication Date
FR2160542A1 FR2160542A1 (cg-RX-API-DMAC7.html) 1973-06-29
FR2160542B1 true FR2160542B1 (cg-RX-API-DMAC7.html) 1976-04-23

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7240734A Expired FR2160542B1 (cg-RX-API-DMAC7.html) 1971-11-17 1972-11-16

Country Status (10)

Country Link
JP (1) JPS5512002B2 (cg-RX-API-DMAC7.html)
AT (1) AT332539B (cg-RX-API-DMAC7.html)
BE (1) BE791489A (cg-RX-API-DMAC7.html)
CH (1) CH588867A5 (cg-RX-API-DMAC7.html)
DD (1) DD102410A5 (cg-RX-API-DMAC7.html)
DE (1) DE2157148A1 (cg-RX-API-DMAC7.html)
FR (1) FR2160542B1 (cg-RX-API-DMAC7.html)
GB (1) GB1416544A (cg-RX-API-DMAC7.html)
NL (1) NL7215221A (cg-RX-API-DMAC7.html)
SE (1) SE406419B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
AU4902772A (en) 1974-05-23
JPS5512002B2 (cg-RX-API-DMAC7.html) 1980-03-29
SE406419B (sv) 1979-02-12
FR2160542A1 (cg-RX-API-DMAC7.html) 1973-06-29
GB1416544A (en) 1975-12-03
ATA975872A (de) 1976-01-15
CH588867A5 (cg-RX-API-DMAC7.html) 1977-06-15
NL7215221A (cg-RX-API-DMAC7.html) 1973-05-21
AT332539B (de) 1976-10-11
BE791489A (fr) 1973-05-16
DE2157148A1 (de) 1973-05-24
JPS4861621A (cg-RX-API-DMAC7.html) 1973-08-29
DD102410A5 (cg-RX-API-DMAC7.html) 1973-12-12

Similar Documents

Publication Publication Date Title
DK139823C (cg-RX-API-DMAC7.html)
FR2120784A5 (cg-RX-API-DMAC7.html)
FI53354B (cg-RX-API-DMAC7.html)
FR2152660B1 (cg-RX-API-DMAC7.html)
DK139788C (cg-RX-API-DMAC7.html)
JPS5512002B2 (cg-RX-API-DMAC7.html)
DK137081C (cg-RX-API-DMAC7.html)
CS149839B1 (cg-RX-API-DMAC7.html)
DE2102522A1 (cg-RX-API-DMAC7.html)
CS160267B1 (cg-RX-API-DMAC7.html)
CS158961B1 (cg-RX-API-DMAC7.html)
CS158770B1 (cg-RX-API-DMAC7.html)
CS150066B1 (cg-RX-API-DMAC7.html)
CS161612B1 (cg-RX-API-DMAC7.html)
CS149073B1 (cg-RX-API-DMAC7.html)
CS155684B1 (cg-RX-API-DMAC7.html)
DE2102080A1 (cg-RX-API-DMAC7.html)
CS153837B1 (cg-RX-API-DMAC7.html)
CH561729A5 (cg-RX-API-DMAC7.html)
CH570075A5 (cg-RX-API-DMAC7.html)
CH561841A5 (cg-RX-API-DMAC7.html)
CH566811A5 (cg-RX-API-DMAC7.html)
DD98798A2 (cg-RX-API-DMAC7.html)
CH547388A (cg-RX-API-DMAC7.html)
CH574957A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse